bioRxivMicrobiology
Screening anti-infectious molecules against Mycobacterium ulcerans: a step towards decontaminating environmental specimens.
Abstract
Mycobacterium ulcerans, a non-tuberculous mycobacterium responsible for Buruli ulcer, is residing in poorly defined environmental niches in the vicinity of stagnant water points where very few isolates have been confirmed. In the perspective of culturing M. ulcerans from such contaminated environmental specimens, we tested the in vitro susceptibility of M. ulcerans CU001 strain co-cultivated with XTC cells to anti-infectious molecules registered in the French pharmacopoeia, using a standardised concentration, to find-out molecules inactive against M. ulcerans which could be incorporated in decontaminating solution. Of 116 tested molecules, 64 (55.1%] molecules including 34 (29.3%] antibiotics, 14 (12%] antivirals, 8 (6.8%] antiparasitic and 8 (6.8%] antifungals were ineffective against M. ulcerans CU001; leaving 52 molecules active against M. ulcerans CU001. Three such inactive antimicrobial molecules (oxytetracycline, polymyxin E and voriconazole] were then selected to make a decontamination solution shown to respect M. ulcerans CU001 viability. These three antimicrobials could be incorporated into a decontamination solution for the tentative isolation and culture of M. ulcerans from environmental samples.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans
E. Saez-Lopez, A. C. Millan Placer, … S. Ramon-Garcia·bioRxiv·Dec 18, 2023
- Q203 containing fully intermittent oral regimens exhibited high sterilizing activity against Mycobacterium ulcerans in mice
A. Chauffour, J. Robert, … V. Jarlier·bioRxiv·Oct 21, 2019
- Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection
A. G. Fraga, G. Trigo, … J. Pedrosa·bioRxiv·Dec 27, 2018
- Mycolactone-independent pathogenicity of Mycobacterium ulcerans: an experimental study in plants.
A. Bouam, M. Drancourt·bioRxiv·Dec 6, 2019
- Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
M. P. Arenaz Callao, R. Gonzalez del Rio, … S. Ramon-Garcia·bioRxiv·Oct 11, 2018
- Experimental pieces of evidence for Mycobacterium ulcerans dormancy.
M. Drancourt, A. Loukil, … N. HAMMOUDI·bioRxiv·Aug 27, 2020